Daily irradiation versus irradiation at two- to three-day intervals in stereotactic radiotherapy for patients with 1-5 brain metastases: study protocol for a multicenter open-label randomized phase II trial

Peer Review reports

Original Submission
25 Oct 2022	Submitted	Original manuscript
16 Nov 2022	Author responded	Author comments - Natsuo Tomita
Resubmission - Version 2
16 Nov 2022	Submitted	Manuscript version 2
22 Nov 2022	Author responded	Author comments - Natsuo Tomita
Resubmission - Version 3
22 Nov 2022	Submitted	Manuscript version 3
Publishing
24 Nov 2022	Editorially accepted
5 Dec 2022	Article published	10.1186/s12885-022-10371-3

Back to article page